ESC Professional Premium Access

Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry

Congress Presentation

About the speaker

Assistant Professor Hee Tae Yu

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))
0 follower

7 more presentations in this session

Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: A nationwide cohort study

Speaker: Associate Professor D. Pastori (Rome, IT)


Body mass index from the RE-LY trial: further evidence of the obesity paradox

Speaker: Doctor M. Jacobs (Stony Brook, US)


Management of atrial fibrillation by different medical specialties in the UK: AF-GEN-UK study

Speaker: Doctor A. Shantsila (Liverpool, GB)


Patterns of anticoagulant prescribing and renal function changes in patients with atrial fibrillation

Speaker: Doctor C. Olesovsky (Toronto, CA)


Comparative validation of the HAS-BLED and the GARFIELD-AF bleeding risk scores in Asian patients with atrial fibrillation: a report from the COOL-AF registry

Speaker: Doctor P. Chichareon (Hat Yai, TH)


Access the full session

Oral anticoagulation in real life

Speakers: Assistant Professor H. Yu, Associate Professor D. Pastori, Doctor M. Jacobs, Doctor A. Shantsila, Doctor C. Olesovsky...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb